Quantitative sensory testing in oral disorders: an update on methods and clinical implications Authors: Myong-Hwan Karm, Seung-Hwa Ryoo, Kwang-Suk Seo, Mi Hyun Seo, Mi-Sun Kong, Hyun Jeong Kim Published: 2026 ABSTRACT AbstractOral mucosal diseases, such as burning mouth syndrome, oral lichen planus, oral mucositis, and recurrent aphthous stomatitis, frequently present with altered sensory functions, including pain, dysesthesia, and changes in thermal and mechanical sensitivity. Accurate assessment of these sensory changes is essential for understanding disease mechanisms, evaluating treatment efficacy, and improving patient outcomes. This review summarizes current evidence on sensory measurement methods used in clinical trials involving patients with oral mucosal diseases, with a particular focus on quantitative sensory testing techniques.Keywords: Burning Mouth Syndrome, Mucositis, Oral Lichen Planus, Oral Mucosa, Pain Assessment, Sensory Measurement INTRODUCTION Oral mucosal diseases comprise a heterogeneous group of conditions involving structural and functional alterations of the oral mucosa, often accompanied by sensory disturbances, such as pain, burning sensations, dysesthesia, and altered thermal or mechanical sensitivity. Common disorders in this category include burning mouth syndrome (BMS), oral lichen planus (OLP), recurrent aphthous stomatitis (RAS), and oral mucositis. These conditions are clinically important because of their high frequency and substantial impact on the quality of life. The pooled prevalence of BMS in the general population has been estimated at 1.73%, whereas the global pooled prevalence of OLP is approximately 1.01% [1,2]. RAS affects approximately 5–25% of the general population [3]. In contrast, oral mucositis is more appropriately described in terms of treatment-related incidence rather than population prevalence, with a mean incidence of approximately 80% among patients receiving radiotherapy for head and neck cancer [4]. Understanding the sensory characteristics of these conditions is essential for accurate diagnosis, elucidating underlying mechanisms, and evaluating therapeutic interventions. Quantitative sensory testing (QST) has emerged as a valuable tool for assessing somatosensory function in various pain conditions and neuropathies [5]. QST encompasses a battery of psychophysical tests that quantify sensory perception in response to controlled stimuli of varying intensities and modalities [5,6]. In the context of oral mucosal diseases, QST can detect subtle changes in sensory function that may not be apparent through clinical examination alone, potentially revealing underlying neuropathic mechanisms or small fiber dysfunction [7,8]. The application of sensory measurement methods to the oral mucosa presents unique challenges compared to extraoral or cutaneous testing. The oral cavity's complex anatomy, dense innervation, moisture, and constant movement require specialized sensory assessment equipment and protocols [9]. In addition, regional variations in mucosal sensitivity necessitate careful selection of anatomical testing sites. Despite these challenges, clinical trials increasingly use QST and other sensory measurement techniques to characterize oral mucosal diseases and evaluate treatment outcomes [7,8,10]. This review aims to synthesize the current evidence on the sensory measurement methods used in clinical trials involving patients with oral mucosal diseases. We focused on the technical aspects of various measurement techniques; their clinical applications across different mucosal conditions; and the reliability, validity, and clinical relevance of the methods. This review seeks to guide researchers and clinicians in selecting appropriate methods for clinical trials and inform the development of standardized protocols for oral mucosal sensory assessment by providing a comprehensive overview of the available sensory measurement approaches. METHODS OF SENSORY MEASUREMENT 1. Thermal quantitative sensory testing Thermal QST assesses the function of small-diameter nerve fibers (Aδ and C fibers) by measuring detection and pain thresholds for cold and warm stimuli [11]. This method has been extensively applied in clinical trials of oral mucosal diseases, particularly BMS [10]. 1) Detection thresholds The cold detection threshold (CDT) and warm detection threshold measure the minimum temperature change that a patient can perceive from baseline (typically 32℃). In clinical studies of BMS, these thermal detection thresholds have been assessed at various intraoral sites, including the tongue tip, lateral borders of the tongue, and buccal mucosa [10,12]. 2) Thermal pain thresholds The heat pain threshold (HPT) and cold pain threshold quantify the temperature at which thermal stimuli become painful. These parameters assess the function of the nociceptive pathways and can help identify thermal hyperalgesia or hypoalgesia. Thermal and mechanical QST studies in Chinese patients with BMS have shown that approximately 50% of the patients exhibit abnormal thermal pain thresholds, suggesting the presence of small-fiber neuropathy [13]. In this study, a Medoc TSA-II NeuroSensory Analyzer equipped with a 9 cm2 thermode adapted for intraoral use was employed to demonstrate the feasibility of standardized thermal pain assessment in the oral cavity. 3) Thermal sensory limen and paradoxical heat sensation The thermal sensory limen assesses the ability to discriminate between warm and cold stimuli through alternating temperature changes. Paradoxical heat sensation occurs when cold stimuli are perceived as warm, indicating a dysfunction in thermal sensory integration [5]. These parameters have been incorporated into comprehensive QST batteries for patients with BMS, demonstrating that peripheral BMS subgroups, those responding to a lingual nerve block, exhibit more localized thermal abnormalities than the central subgroups [10]. 4) Technical considerations Intraoral thermal testing requires specialized thermodes with appropriate size and shape for oral mucosa contact. Contact pressure must be standardized to ensure reproducible measurements. Additionally, saliva management is critical, as moisture can affect thermal conductivity. Most studies employ a baseline temperature of 32℃, and temperature change rates of 1℃/s for detection thresholds and 1–2℃/s for pain thresholds [5,14]. The limited surface area of certain intraoral sites may require the use of smaller thermodes compared with extraoral testing, which may influence the absolute threshold values. To address these technical challenges, various modular thermodes have been developed to accommodate different intraoral sites and test requirements (Fig. 1). Suite of modular thermodes for multimodal thermal quantitative sensory testing. The image shows a set of specialized thermodes designed for a computerized thermal sensory analyzer. These modular probes illustrate the adaptability required to assess different anatomical sites and somatosensory mechanisms. (A) A small-diameter circular thermode, optimized for intraoral application to areas such as the tongue tip, buccal mucosa, or other localized sites where limited surface area requires high spatial precision. (B) A specialized curved-surface thermode with a concave design that allows standardized contact with nonplanar surfaces. (C) An air-cooled or ventilated thermode designed to maintain a stable baseline temperature without water cooling, which may be useful in settings where water-related artifact should be avoided. (D) A large-diameter square thermode, commonly used for broad, planar surfaces such as the volar forearm, enabling efficient assessment of both detection and pain thresholds through greater spatial summation. All thermodes are connected by durable braided cables to support stable operation and reliable signal transmission. 2. Mechanical sensory testing Mechanical sensory testing evaluates the function of mechanoreceptors and mechanosensitive nociceptors by applying controlled mechanical forces to the oral mucosa. 1) Mechanical detection threshold The mechanical detection threshold is typically assessed using a standardized set of von Frey filaments that deliver calibrated forces when applied perpendicularly to the oral mucosa until each filament bends (Fig. 2). These instruments enable comprehensive characterization of mechanosensory function in oral mucosal disorders. Representative device for mechanical sensory testing in the oral mucosa. Mechanical sensory testing evaluates the function of distinct mechanosensitive nerve fibers. (Top) Selected weighted pinprick stimulators are shown. (Left) A calibrated weighted pinprick stimulator set is used to measure mechanical pain threshold and wind-up ratio, thereby assessing the integrity of Aδ- and C fiber-mediated nociceptive pathways. Individual stimulators with color-coded handles represent specific force categories. (Right) Traditional Semmes–Weinstein (von Frey) monofilaments are used to assess the function of low-threshold mechanoreceptors mediated by Aβ fibers. 2) Mechanical pain threshold The MPT is typically assessed using calibrated pinprick stimulators or weighted needles that deliver standardized forces. Mechanical pain testing has been incorporated into comprehensive QST batteries to detect small-fiber neuropathies in patients with BMS and iatrogenic lingual nerve injuries [15]. In these protocols, weighted pinprick stimulators ranging from 8 to 512 mN were applied perpendicularly to the mucosa until the patient reported pain. The findings showed that patients with BMS exhibited significantly elevated MPT values compared to controls, indicating mechanical hypoalgesia consistent with small-fiber dysfunction. 3) Wind-up ratio Wind-Up Ratio (WUR) assesses the temporal summation of pain, which reflects central sensitization. It compares the pain intensity elicited by a single pinprick stimulus with that produced by a series of repeated stimuli delivered using the same force. WUR has been included in the QST protocols for patients with BMS, and a higher WUR has been observed in central BMS subgroups, suggesting enhanced central pain processing [10]. This parameter provides useful insights into central and peripheral pain mechanisms in oral mucosal diseases. 3. Tactile sensitivity measurement Tactile sensitivity assessment evaluates the function of low-threshold mechanoreceptors, primarily mediated by large-diameter Aβ fibers [5,16]. 1) Von Frey filaments Von Frey monofilaments are the most widely used method for assessing tactile thresholds in the oral mucosa. These calibrated nylon filaments deliver specific forces when applied perpendicularly to the tissue until they bend. Von Frey filaments ranging from 0.008 g to 300 g have been used to evaluate the influence of topical agents on intraoral somatosensory sensitivity in healthy subjects [17]. These studies demonstrated the good reliability of tactile testing in the oral mucosa and revealed regional variations in sensitivity, with the tongue tip being the most sensitive site. Von Frey filaments have also been used to assess tactile detection thresholds before and after capsaicin and menthol application to the oral mucosa, thereby establishing baseline sensitivity values for various intraoral sites [18]. The thresholds were determined using the method of limits with ascending and descending series, and at least three measurements were obtained at each site and averaged. 2) Electronic von Frey devices Electronic von Frey devices provide continuous force measurements and offer advantages over traditional filaments in terms of precision and ease of use [19]. However, their application in oral mucosa research has been limited, and most studies continue to use traditional monofilaments because of their established reliability and lower cost [20]. Fig. 3 compares the traditional von Frey filaments with modern electronic devices used for tactile sensitivity measurements in clinical research. Representative traditional von Frey filaments and modern electronic devices used for tactile sensitivity measurement in the oral mucosa. Assessment of tactile sensitivity, which is primarily mediated by large-diameter Aβ fibers, commonly uses two main types of instruments. (Left) Traditional Semmes–Weinstein monofilaments (von Frey filaments) consist of a series of nylon filaments with varying diameters calibrated to deliver specific forces. These remain a standard tool in oral mucosal research because of their established reliability, cost-effectiveness, and ease of application in confined intraoral sites. (Right) An electronic von Frey device incorporates a pressure transducer to provide continuous force measurement and real-time digital display. Although it offers greater precision and eliminates the need for multiple filaments, its intraoral application may be limited by device size and the difficulty of maintaining standardized contact in a moist environment. 3) Two-point discrimination Two-point discrimination (TPD) assesses spatial acuity by determining the minimum distance at which two simultaneously applied points are perceived as distinct (Fig. 4). Although TPD has been widely used in extraoral sensory testing, its application to the oral mucosa is limited by the small surface area of many intraoral sites and technical challenges in maintaining consistent probe orientation. Early investigations of oral surface sensation included TPD measurements and established baseline values for various intraoral sites [21]. Two-point discrimination testing performed on the tongue using dual probes to assess intraoral spatial sensory acuity and somatosensory function. 4. Pressure pain threshold assessment The pressure pain threshold (PPT) quantifies the minimum pressure that induces pain, providing information about deep tissue sensitivity and nociceptor function. 1) Algometry techniques Pressure algometry is the standard method for assessing the PPT. Digital algometers with flat or rounded probes (typically with a 1 cm2 contact area) were applied perpendicularly to the tissue with a gradually increasing force until the patient reported the onset of pain. A validation study of PPT determination in the oral mucosa has established the reliability and validity of this method [22]. The study tested 12 intraoral sites in healthy subjects and found excellent test-retest reliability (intraclass correlation coefficients 0.70–0.90) and demonstrated that PPT values varied significantly across different oral sites. Standardized determination of PPTs in the orofacial region is typically achieved using a digital pressure algometer (Fig. 5). Digital pressure algometer for standardized pressure pain threshold assessment. A digital pressure algometer with a standardized probe can be used to assess pressure pain thresholds by applying gradually increasing force perpendicular to the target tissue until the participant indicates the onset of pain [53,54]. Mechanical sensitivity in patients with BMS has been evaluated using pressure algometry applied to the tongue, showing that patients with BMS exhibit lower PPT values, indicating increased sensitivity compared with controls. In addition, PPT values were correlated with psychological factors, including anxiety and depression [23]. The study used a 1 cm2 probe with a force application rate of 50 kPa/s, demonstrating a standardized methodology for intraoral PPT assessment. This quantitative approach enables the identification of mechanical hyperalgesia in conditions such as BMS, and supports the correlation of pain thresholds with clinical and psychological factors. 2) Site-specific considerations PPT measurement in the oral mucosa requires careful consideration of site-specific anatomical characteristics. Keratinized mucosa, such as the hard palate and attached gingiva, typically exhibit higher PPT values than non-keratinized mucosa, such as the buccal mucosa and the ventral surface of the tongue. Measurements may also be influenced by the presence of the underlying bone or teeth, making consistent probe placement essential. PPT assessment has been shown to be feasible even in inflamed gingival tissues, including measurements taken at the gingiva adjacent to the maxillary first premolar in patients with plaque-induced gingivitis [24]. 3) Influence of oral conditions Regarding factors that may influence PPT measurements in the oral cavity, oral dryness has been shown to affect pressure pain sensitivity in removable denture wearers, with xerostomia being associated with lower PPT values, indicating increased sensitivity, in denture-bearing mucosa [25]. Aging and tooth loss have been reported to influence sensory function in the alveolar mucosa, with edentulous alveolar ridges exhibiting altered PPT compared to dentate sites [26]. 5. Specialized sensory testing methods 1) Electrogustometry Electrogustometry assesses taste function by applying electrical stimulation to the tongue that elicits a metallic or sour taste sensation. Although it is primarily used to evaluate gustatory function, electrogustometry also provides information regarding the integrity of the chorda tympani nerve fibers. In patients with BMS, elevated taste detection thresholds have been observed in approximately 30% of cases, suggesting that dysfunction of taste pathways may contribute to the pathophysiology of BMS [27]. This method uses a constant-current stimulator with a monopolar electrode applied to specific regions of the tongue, and thresholds are determined using the ascending method of limits. The clinical setup and standardized procedure for assessing gustatory function using electrogustometry are shown in Fig. 6. Electrogustometry setup and procedure for gustatory function assessment. Electrogustometry is a psychophysical method used to quantify taste detection thresholds by applying a controlled electrical current to the tongue. A constant-current stimulator delivers precise microampere (µA) pulses, with the intensity gradually increased using the ascending method of limits until a metallic/sour sensation is first perceived. A monopolar electrode is applied to specific anatomical regions, including the tongue tip and lateral borders, to evaluate the functional integrity of the chorda tympani nerve. 2) Argon laser stimulation Argon laser stimulation is a noncontact method for assessing nociceptive function. Svensson et al. pioneered the use of an argon laser for sensory and pain threshold assessments in patients with BMS [28]. This method delivers controlled radiant heat pulses to the oral mucosa without mechanical contact, eliminating the confounding effects of pressure. Patients with BMS exhibited elevated pain thresholds for laser stimulation, suggesting hypoalgesia to heat pain. However, specialized equipment requirements and technical complexities have limited the widespread adoption of this method. 3) Capsaicin and menthol challenge tests Topical application of capsaicin (TRPV1 agonist) and menthol (TRPM8 agonist) enables the functional assessment of specific nociceptor populations. Previous studies have demonstrated the temporal and spatial effects of capsaicin and menthol on intraoral somatosensory sensitivity, showing that these agents produce reproducible changes in thermal and mechanical thresholds [17]. Detailed somatosensory profiling indicated that capsaicin primarily affected heat sensitivity, whereas menthol predominantly influenced cold sensitivity [18]. In addition, repeated administration of capsaicin gel over 14 days caused desensitization to heat pain in the oral thermal QST [29]. 4) Quantitative sensory testing of open wounds Specialized QST protocols for open intraoral wounds have demonstrated that sensory testing can be performed even in acutely injured mucosa. Using modified thermal and mechanical testing protocols with reduced stimulus intensities, wound edges were found to exhibit hyperalgesia, whereas wound centers showed hypoalgesia, providing insight into the wound healing processes [30]. The technical specifications, measured parameters, and clinical applications of the various sensory testing modalities discussed in this section are summarized in Table 1. Table 1 provides a comprehensive overview of the available tools for characterizing the somatosensory profile of the oral mucosa and their potential clinical applications. Table 1Summary of sensory measurement methods and target nerve fibersCategoryMeasurement methodPrimary target fiberClinical significanceThermal QSTWarm detection threshold Cold detection threshold Heat pain threshold Cold pain thresholdC fibers Aδ fibers C fibers (partly Aδ) Aδ and C-fibersDetection of small fiber neuropathy Detection of small fiber neuropathy Assessment of heat hyperalgesia Assessment of cold hyperalgesiaMechanical QSTMechanical detection threshold Mechanical pain threshold Pressure pain thresholdAβ fibers Aδ fibers Aδ and C fibersTactile sensitivity assessment Assessment of pinprick hyperalgesia Deep tissue & muscle pain assessmentOthersElectrogustometryChorda tympani nerveTaste threshold & nerve integrityQST, quantitative sensory testing. Summary of sensory measurement methods and target nerve fibers QST, quantitative sensory testing. CLINICAL APPLICATIONS IN MUCOSAL DISEASES 1. Oral pain disorders without objective mucosal lesions 1) Burning mouth syndrome BMS, the most extensively studied oral pain disorder using sensory measurement methods, is characterized by chronic burning pain in the oral mucosa without clinically evident lesions, predominantly affecting postmenopausal women [23,31]. (1) Somatosensory profiling and small-fiber neuropathy detection Multiple studies have employed comprehensive QST batteries to characterize somatosensory function in the BMS. Somatosensory profiling using a standardized QST protocol in 62 patients identified three distinct sensory phenotypes: sensory loss (40%), sensory gain (25%), and normal sensory function (35%) [32]. The distribution of these distinct sensory phenotypes among patients with BMS, reflecting the underlying pathophysiological heterogeneity, is shown in Table 2. Sensory phenotypes were also associated with psychological factors, with the sensory loss phenotype showing higher depression scores. This heterogeneity in sensory profiles suggests that BMS involves multiple pathophysiological mechanisms. Table 2Sensory phenotypes and underlying Pathophysiological mechanism in patients with burning mouth syndrome (BMS)PhenotypeProportionPathophysiological mechanismSensory loss40%Peripheral neuropathy, particularly small fiber dysfunctionSensory gain25%Central sensitization and pain amplificationNormal sensory function35%Functional pain with predominant central and psychosocial modulation Sensory phenotypes and underlying Pathophysiological mechanism in patients with burning mouth syndrome (BMS) Patients with BMS predominantly exhibited thermal sensory deficits, whereas those with lingual nerve injury exhibited both thermal and mechanical deficits. This distinction has significant diagnostic implications. A comparison of intraoral neuropathic disturbances between patients with BMS and those with lingual nerve injury showed that both groups exhibited somatosensory abnormalities, but with distinct patterns [33]. QST has been shown to be particularly valuable for detecting small-fiber neuropathies in BMS, demonstrating that comprehensive QST can identify small-fiber dysfunction in approximately 65% of patients, with thermal detection thresholds being the most sensitive parameters [15]. QST abnormalities in BMS were comparable to those observed in patients with confirmed iatrogenic lingual nerve injuries, supporting the neuropathic etiology of BMS. QST abnormalities were more prevalent in patients with longer symptom duration, suggesting progressive nerve fiber dysfunction. Approximately 50% of Chinese patients with BMS exhibited QST abnormalities consistent with small-fiber neuropathy, with the CDT being the most frequently impaired parameter [13]. In addition to these diagnostic insights, evaluation of treatment efficacy through standardized outcomes is essential. A recent meta-analysis showed that alpha-lipoic acid significantly reduces pain intensity in patients with BMS, providing further evidence that pharmacological modulation can effectively target these neuropathic symptoms [34]. (2) Peripheral versus central mechanisms Recent research has used the QST to differentiate peripheral from central pain mechanisms in BMS. A randomized, double-blind, crossover trial examined the effects of lingual nerve block on pain and somatosensory function in patients with BMS [10]. The study classified patients into peripheral (45%) and central (55%) subgroups based on the pain response to nerve block. Patients with peripheral BMS exhibited localized somatosensory abnormalities at the painful site, whereas patients with central BMS showed more widespread sensory changes and higher wind-up ratios, indicating central sensitization. (3) Temporal aspects The association between somatosensory dysfunction and symptom duration in BMS indicates that patients with a longer disease duration exhibit more severe abnormalities in thermal detection thresholds [35]. This temporal relationship suggests progressive small-fiber degeneration in BMS and has implications for early intervention strategies. (4) Hormonal influences Hormonal factors may influence sensory function in patients with BMS. Differences in somatosensory function across menopausal stages in patients with BMS have been investigated, demonstrating that individuals in the late postmenopausal stage exhibit more pronounced abnormalities in thermal detection thresholds than those who are premenopausal or in the early postmenopausal [36]. (5) Psychological correlations Honda et al. demonstrated significant correlations between mechanical sensitivity and psychological factors in patients [23]. Lower PPT values (increased sensitivity) were correlated with higher anxiety and depression scores, suggesting complex interactions between sensory and psychological factors in BMS pathophysiology. 2) Atypical odontalgia Prolonged gingival cold allodynia has also been reported in patients with atypical odontalgia who exhibit persistent cold hypersensitivity in the gingival tissues adjacent to previously treated teeth [37]. This finding supports the involvement of neuropathic mechanisms in atypical odontalgia and further demonstrates the value of thermal QST in the differential diagnosis of oral pain. 3) Diabetic peripheral neuropathy The assessment of trigeminal nociceptive and oral somatosensory functions in patients with diabetic peripheral neuropathy has shown that diabetic patients exhibit elevated thermal detection thresholds and altered mechanical sensitivity of the oral mucosa [38]. These findings indicate that systemic neuropathies can influence oral sensory function and underscore the importance of considering underlying systemic conditions when interpreting oral QST results. 2. Oral disorders with objective mucosal lesions 1) Oral lichen planus OLP is a chronic inflammatory mucosal disease that can present with pain, particularly in erosive forms [39]. Sensory measurement in OLP has received less attention than in BMS, but provides important insights into pain mechanisms. One of the few studies specifically investigating thermal sensation and pain in patients with OLP demonstrated distinct differences according to lesion type [39]. This study evaluated the cold and HPTs at OLP lesion sites and the corresponding contralateral healthy mucosa. The results showed that erosive OLP lesions exhibited significantly lower HPTs than healthy mucosal sites, indicating thermal hyperalgesia. In contrast, non-erosive OLP lesions did not show significant differences in thermal pain thresholds relative to the healthy mucosa. These findings suggest that pain in OLP is more closely related to mucosal erosion than to the underlying inflammatory process. Recent evidence-based reviews have shown that several therapeutic interventions, including photodynamic therapy, can effectively reduce both pain intensity and clinical severity of OLP lesions [40]. Comparative studies have shown that patients with OLP and oral lichenoid reactions exhibit similar patterns of thermal pain sensitivity, suggesting that sensory alterations in OLP may be more closely related to mucosal damage than to distinct immunopathological mechanisms that differentiate OLP from lichenoid reactions [39]. Despite the high prevalence of pain in erosive OLP, the routine application of comprehensive QST batteries is inherently limited, as diagnosis and disease monitoring are primarily and effectively achieved through clinical and histopathological assessments. Therefore, future QST research on OLP should be strictly targeted rather than broadly applied. Focused sensory testing may be clinically valuable to objectively evaluate the efficacy of novel topical pain interventions, determine whether baseline sensory hyperalgesia can predict a patient's response to symptomatic treatments, and clarify the precise mechanistic relationship between mucosal inflammation and peripheral nociceptor sensitization beyond what is visible clinically. 2) Oral mucositis Oral mucositis, a common complication of cancer therapy, is associated with severe pain and substantial functional impairment [41]. Although pain intensity in mucositis has been widely assessed using visual analog scales and numerical rating scales, relatively few studies have applied QST to characterize the underlying sensory alterations [7]. Ettlin et al.’s study of open intraoral wounds provided a relevant methodological framework for mucositis assessment, demonstrating that sensory testing can be feasibly performed in acutely damaged oral mucosa and revealed distinct sensory patterns, with hyperalgesia at wound edges and hypoalgesia at wound centers [30]. These findings may help elucidate the pain mechanisms in mucositis and inform the targeted use of topical analgesics. Although not specifically investigated in mucositis, studies demonstrating reliable measurement of PPTs in inflamed gingival tissue, support the feasibility of applying similar objective sensory testing approaches in mucositis trials [24]. Therefore, integrating QST into clinical studies of oral mucositis may provide valuable insights into pain mechanisms, help identify patients at a greater risk of severe pain, and offer an objective means of evaluating analgesic interventions. Furthermore, longitudinal QST assessment over the course of mucositis may clarify the temporal patterns of sensory dysfunction and their relationship with mucosal healing. 3) Other mucosal conditions Although RAS is a common painful oral condition, specific QST studies on RAS patients are lacking in the current literature [7,8]. Methodologies established for other mucosal conditions could be readily applied to RAS research to characterize sensory changes during the active ulceration and healing phases. Somatosensory profiling of patients with plaque-induced gingivitis has shown that even relatively mild inflammatory conditions can produce measurable alterations in sensory function. In that study, patients with gingivitis exhibited lower pressure pain thresholds, indicating increased mechanical sensitivity and altered thermal detection thresholds, compared with healthy controls [24]. These findings support the sensitivity of QST for detecting subtle inflammation-related sensory changes in the oral mucosa. The characteristic sensory profiles and principal QST findings for the major oral mucosal diseases discussed in this section are summarized in Table 3. This comparative overview highlights the heterogeneity of somatosensory abnormalities across conditions, ranging from thermal sensory deficits in BMS to thermal hyperalgesia in erosive OLP and underscores the clinical value of standardized sensory testing in identifying distinct pathophysiological patterns of oral mucosal disease. These findings demonstrated that even mild inflammatory conditions can produce measurable sensory changes, validating the sensitivity of QST methods. Table 3Representative sensory profiles in major oral mucosal diseasesDisease conditionKey sensory findingsKey reference(s)Burning mouth syndromeElevated thermal/mechanical thresholds, taste dysfunctionYang et al. (2025) [10] Braud et al. (2015) [27] Madariaga et al. (2020) [48]Oral lichen planusThermal hyperalgesia (especially in erosive lesions)Niissalo et al. (2003) [39] Stella, et al. (2007) [29]Oral mucositisSevere spontaneous pain, Inflammatory & wound-related hypersensitivityTrotti et al. (2003) [4] Ettlin et al. (2015) [30] Pigg et al. (2010) [9]Recurrent aphthous stomatitisAcute nociceptive pain, localized sensory changesShip et al. (2000) [3] Representative sensory profiles in major oral mucosal diseases RELIABILITY, VALIDITY, AND CLINICAL RELEVANCE 1. Psychometric properties of measurement methods 1) Reliability and validity Test-retest reliability is essential for the longitudinal use of the QST in clinical trials. A comprehensive validation study of PPT measurement in the oral mucosa demonstrated excellent test-retest reliability, with intraclass correlation coefficients ranging from 0.70 to 0.90 across different intraoral sites [22]. In that study, 30 healthy participants were examined on two occasions separated by one week, confirming that PPT measurements are sufficiently stable for use in clinical research. The reliability of thermal QST has been established mainly in extraoral studies; however, intraoral validation remains limited. Nevertheless, several studies have successfully applied thermal QST to repeated-measure designs, suggesting acceptable reliability in the oral cavity. In addition, repeated measurements in healthy subjects demonstrated good reliability for both the thermal and mechanical testing of the oral mucosa [17]. Although inter-rater reliability is generally less critical for QST than for examiner-dependent clinical assessments because QST is based primarily on patient responses to standardized stimuli, strict standardization of testing procedures, including stimulus application methods and patient instructions, remains essential to ensure reproducibility across examiners and study centers. The construct validity of oral QST methods is supported by their ability to detect the expected sensory abnormalities in neuropathic conditions. The QST can distinguish patients with BMS, those with iatrogenic lingual nerve injury, and healthy controls, thereby supporting the construct validity of this approach [15]. Additionally, the observed QST abnormalities were associated with clinical pain characteristics, providing further evidence of validity. Criterion validity was examined by comparison with other diagnostic approaches. In one study evaluating the diagnostic accuracy of QST for differentiating inflammatory toothache from intraoral neuropathic pain, thermal QST parameters showed a sensitivity of 0.73 and a specificity of 0.82 for the diagnosis of neuropathic pain [42]. These findings support the utility of the QST as a valid tool for distinguishing pain mechanisms in oral conditions. Furthermore, discriminant validity has been demonstrated by studies showing that the QST can differentiate not only between patients and healthy controls, but also among distinct oral pain disorders. For example, different QST profiles in patients with BMS and those with lingual nerve injury further support the discriminant validity of the oral QST [33]. 2) Sensitivity to change Sensitivity to change is a critical property of the QST when evaluating treatment effects in clinical trials. QST parameters change significantly after lingual nerve block in patients with peripheral BMS, indicating that the QST is responsive to therapeutic interventions [10]. Similarly, thermal QST detects alterations in sensory function following repeated capsaicin application, providing further evidence of its sensitivity to changes [29]. These findings support the usefulness of the QST as an outcome measure for monitoring treatment-related changes in oral somatosensory function [29]. 2. Methodological considerations 1) Anatomical site selection The selection of appropriate anatomical sites is critical for accurate sensory testing of the oral cavity because substantial regional variations in mucosal sensitivity have been demonstrated. The tongue tip exhibits the highest tactile sensitivity, whereas the hard palate has the lowest [21]. Therefore, for disease-specific assessment, sensory testing should be conducted at both the symptomatic site and a contralateral or anatomically distant control site to allow meaningful comparisons. This approach has been applied in BMS studies, in which testing was performed at the site of greatest pain, as well as at an intraoral control site [10]. 2) Normative reference values A major challenge in oral QST is the lack of standardized normative reference values. Various studies used different equipment, protocols, and anatomical sites, making it difficult to establish universal normal ranges. Mochizuki conducted a quantitative assessment of warm, cold, and tactile thresholds across multiple oral sites in healthy subjects and provided valuable normative data [43]. However, the age, sex, and ethnic differences in oral sensory thresholds require further investigation. 3) Stimulus parameters Standardization of stimulus parameters is essential to ensure the reproducibility of QST results. For thermal testing, key parameters such as the baseline temperature, which is typically set at 32℃, the rate of temperature change, usually 1–2℃/s, and safety cutoff temperatures, commonly 0℃ for cold and 50℃ for heat, should be clearly specified. For mechanical testing, factors such as the rate of force application, probe size and shape, and the maximum force limits must be standardized. In particular, the rate of force application has been shown to significantly influence PPT values, with slower application rates yielding lower thresholds. These considerations highlight the importance of rigorous protocol standardization to obtain reliable and comparable QST data across studies [22]. 4) Patient education Clear patient instructions and practice trials are essential to obtain reliable QST results. Patients must understand the distinction between detection thresholds, at which a stimulus is first perceived and pain thresholds, at which the stimulus becomes painful. Practice trials performed at extraoral sites, such as the hand may facilitate familiarization with the procedure before intraoral assessment. Early psychophysical studies on BMS highlighted the importance of adequate patient training to improve the consistency and interpretability of sensory testing results [44]. 5) Environmental factors Environmental factors may substantially influence the QST results. Therefore, room temperature should be carefully controlled, typically within the range of 20–24℃, to minimize thermal adaptation effects. In addition, testing should be conducted in a quiet and well-controlled environment to reduce distractions and improve response consistency [5]. The time of day may also affect sensory thresholds, particularly in conditions characterized by diurnal symptom variations, such as BMS [9,44]. Accordingly, controlling environmental conditions and maintaining consistent testing times are important to improve the reliability and comparability of oral QST measurements. 6) Saliva management Saliva may influence QST results by altering both the thermal conductivity and the application of mechanical stimuli [9]. To improve reproducibility, some studies have used gentle air-drying or gauze blotting before testing [22], whereas others have performed assessments without removing saliva to preserve physiological conditions. Regardless of the approach chosen, saliva handling should be standardized within each study and clearly reported to facilitate comparisons across studies. Based on the methodological challenges and technical considerations outlined above, Table 4 summarizes key recommendations for implementing sensory testing in clinical trials. Adherence to these standardized procedures will be fundamental for addressing the future research directions discussed in the following section. Table 4Methodological considerations and standard recommendations for intraoral QSTConsideration factorStandard recommendationsRational / ImpactEnvironmentRoom temp: 20–24℃, quiet roomAvoid thermal adaptation & distractionSaliva managementGentle air drying or gauze blottingMaintain consistent thermal/mechanical contactAnatomical siteDocument specific site (e.g., tongue tip vs. palate)Account for regional variation in receptor densityApplication rateStandardized (e.g., 1℃/s for thermal, 50 kPa/s for pressure)Ensure reproducibility across studiesTime of dayConsistent testing time (especially for BMS)Minimize impact of diurnal variationBMS, burning mouth syndrome; QST, quantitative sensory testing. Methodological considerations and standard recommendations for intraoral QST BMS, burning mouth syndrome; QST, quantitative sensory testing. 7) Infection control and equipment disinfection Given that oral QST involves direct mucosal contact and continuous exposure to saliva, stringent infection control and disinfection protocols are paramount to prevent cross-contamination in clinical trials. For instruments requiring direct contact with the oral mucosa, such as thermal thermodes and pressure algometer probes, the application of thin disposable plastic barriers or sleeves for each participant is recommended to physically isolate the equipment from salivary contamination. Single-use disposable tips are essential for mechanical pain testing using pinprick stimulators, and must be discarded immediately after each session. Furthermore, thorough surface disinfection of the device bodies, cables, and non-disposable components must be performed between participants. Although alcohol-based disinfectants are widely used, they may be insufficient against certain pathogens and potentially degrade sensitive electronic sensors over time. Weakly acidic hypochlorous acid (HOCl) has emerged as an effective and safe disinfectant for orofacial and dental equipment. HOCl exhibits potent broad-spectrum antimicrobial and antiviral efficacy against prominent oral pathogens and respiratory viruses by disrupting microbial protein synthesis and nucleic acids [45]. Importantly, HOCl is highly biocompatible, presenting no cytotoxicity to human mucosal tissues, and its low corrosiveness makes it ideal for disinfecting delicate electronic sensory testing equipment without compromising the sensor or calibration integrity [46]. 3. Clinical utility and interpretation 1) Diagnostic applications QST may contribute meaningfully to the differential diagnosis of oral pain conditions by helping distinguish inflammatory from neuropathic pain mechanisms. One study found that QST could differentiate neuropathic pain from inflammatory pain, with elevated thermal detection and mechanical pain thresholds indicating neuropathic pain and normal or reduced thresholds suggesting inflammatory pain [42]. In addition, the ability of QST to distinguish peripheral from central mechanisms of pain has important therapeutic implications. In BMS, for example, Yang et al. proposed peripheral and central subgroups based on nerve block response and QST profiles, suggesting that different pathophysiological subtypes may require different treatment strategies [10]. These findings support the clinical utility of QST not only as an assessment tool but also as a means of guiding mechanism-based diagnosis and individualized management of oral pain disorders. 2) Prognostic value The observation that the severity of somatosensory dysfunction correlates with symptom duration in BMS suggests that QST may also have prognostic value [35]. Early identification of sensory abnormalities could help detect patients at greater risk of developing persistent or chronic pain, thereby supporting the implementation of earlier and more targeted intervention strategies. 3) Treatment monitoring QST provides objective measures for monitoring treatment effects in patients with oral pain disorders. Changes in the sensory thresholds may reflect therapeutic or treatment-related adverse effects [47]. For instance, the normalization of thermal detection thresholds after treatment may indicate the recovery of small-fiber sensory function. In contrast, the emergence or worsening of sensory abnormalities during therapy may suggest treatment-induced neuropathy or other unfavorable neurosensory changes. These features support the value of QST as an objective tool for tracking treatment responses and detecting clinically relevant sensory alterations over time. 4) Mechanistic insights QST profiles offer important insights into the pathophysiological mechanisms underlying oral pain disorders. Patterns of sensory loss, such as elevated detection thresholds, are generally suggestive of peripheral nerve dysfunction, whereas patterns of sensory gain, including reduced pain thresholds and increased WUR, are more consistent with central sensitization. A systematic review and meta-analysis of the psychophysical characterization of BMS identified marked heterogeneity in sensory profiles, supporting the concept that BMS comprises multiple pathophysiological subtypes [48]. These findings highlight the potential of QST not only as a diagnostic tool but also as a method for mechanism-based phenotyping of patients with oral pain conditions. 5) Limitations QST is a psychophysical method that depends on patient-reported responses and is therefore influenced by factors such as attention, motivation, and psychological state. As a result, patients with cognitive impairment or language barriers may have difficulty completing QST procedures reliably. Although QST is useful for assessing the functional integrity of sensory pathways, it does not directly evaluate nerve structures. Complementary techniques, such as corneal confocal microscopy or skin biopsy, may provide additional information regarding nerve fiber density and morphological alterations. These limitations should be considered when interpreting QST findings and selecting multimodal approaches for comprehensive neurosensory assessment. DISCUSSION This review highlights that QST and other sensory measurement methods can effectively detect subtle somatosensory abnormalities, elucidate pathophysiological mechanisms, and serve as objective outcome measures in clinical trials for oral mucosal diseases. 1. Key findings and clinical implications Thermal QST has emerged as a valuable method for detecting small-fiber neuropathy in patients with BMS, and multiple studies have consistently reported impaired cold and warm detection in approximately 40%–60% of affected patients [10,13,15]. These findings support a neuropathic basis for at least a subset of BMS cases and have important therapeutic implications as neuropathic pain requires management strategies distinct from those used for inflammatory or psychogenic pain. In particular, the ability to classify patients with BMS into peripheral and central subgroups based on QST profiles and responses to nerve blocks represents an important step toward more personalized treatment approaches [10]. Mechanical sensory testing, including tactile detection using von Frey filaments and PPT assessment using algometry, has also demonstrated good reliability in intraoral applications [17,22]. These methods are relatively easier to implement and require less specialized equipment, making them more accessible in a wider range of clinical and research settings, compared to thermal QST. Furthermore, the observation that mechanical sensitivity is correlated with psychological factors in BMS underscores the complex biopsychosocial nature of oral pain disorders and highlights the importance of a comprehensive multidimensional assessment [23]. 2. Methodological challenges and standardization needs A major challenge identified in this review was the limited adherence to and validation of existing standardized protocols across published studies. Although foundational guidelines and recommendations for assessing somatosensory function in orofacial pain conditions have already been established by an international task force [9,49], existing clinical trials frequently use heterogeneous equipment, stimulus parameters, anatomical test sites, and threshold determination methods. This lack of methodological compliance limits direct comparison across studies and hinders the development of normative reference values. Although the German Research Network on Neuropathic Pain has successfully implemented standardized QST protocols for extraoral assessment [5,11], there remains a critical need for researchers to consistently adopt and validate existing intraoral-specific recommendations to account for the distinct anatomical and physiological characteristics of the oral mucosa [7,9]. Regional variation in oral mucosal sensitivity further complicates standardization and necessitates the careful selection of test sites. The tongue tip has been shown to exhibit the highest tactile sensitivity, whereas the hard palate demonstrates the lowest [21,43]. For disease-specific assessments, testing at the symptomatic site is essential; however, the choice of an appropriate control site remains unresolved. Previous studies used contralateral mucosal sites, distant intraoral sites, or even extraoral sites as controls [7,8,9,10], and the optimal strategy may differ according to the conditions under investigation. In addition, normative reference values for oral QST parameters remain limited, particularly across diverse populations. Normative reference values for oral QST parameters are limited, particularly in diverse populations. Although age, sex, and ethnic differences in sensory thresholds have been documented for extra-oral sites, these factors have not been sufficiently characterized in the oral mucosa. Aging and tooth loss influence the sensory function in the alveolar mucosa [26], underscoring the need for age-stratified normative databases. Therefore, future studies should focus on establishing comprehensive reference values and standardizing intraoral QST protocols to improve the comparability, diagnostic utility, and clinical applications. 3. Integration with other assessment methods Although QST provides valuable functional information about sensory pathways, its integration with structural and neurophysiological assessments may further enhance diagnostic accuracy and mechanistic insight [5]. Corneal confocal microscopy has emerged as a non-invasive technique for evaluating small nerve fiber density and morphology, and its potential application in the oral mucosa is currently being explored [50]. In contrast, skin biopsy with the quantification of intraepidermal nerve fiber density remains the gold standard for diagnosing small-fiber neuropathy, although its invasive nature limits its routine use in oral tissues [51]. Neurophysiological methods, such as laser-evoked potentials and contact heat-evoked potentials, may provide complementary information regarding nociceptive pathway function [52]. However, the relationship between QST findings and the structural or histopathological changes in oral mucosal diseases remains unclear. For example, in OLP, it would be informative to determine whether sensory abnormalities correlate with the extent of subepithelial inflammation or epithelial alterations. Similarly, in BMS, correlating QST profiles with tongue biopsy findings or salivary biomarkers may provide important insights into underlying pathophysiological mechanisms. 4. Methodological considerations for QST in clinical trials Several design considerations should be considered when incorporating sensory measurement methods into clinical trials of oral mucosal diseases. Sample size calculations must reflect the variability of QST parameters as well as the expected effect size of the intervention under investigation. Baseline QST assessments may be useful for identifying sensory phenotypes, thereby facilitating stratified randomization or predefined subgroup analyses. Longitudinal QST assessments at multiple time points can help characterize temporal patterns of sensory changes and clarify their relationship with clinical outcomes. The selection of primary and secondary outcome measures is also important. Although patient-reported pain intensity remains the most clinically meaningful primary outcome in pain trials, QST parameters can provide valuable secondary outcomes by offering objective mechanistic information. In certain settings, particularly those evaluating neuroprotective or neuroregenerative interventions, restoration or normalization of sensory function, as measured by QST, may also be considered as a primary outcome, despite only a modest improvement in subjective pain. 5. Gaps and limitations in current evidence Several limitations of the current evidence base should be acknowledged. To date, most oral QST studies have focused on BMS, whereas research on lesion-positive disorders such as OLP, oral mucositis, and RAS remains limited. However, it must be acknowledged that the scarcity of QST data in these lesion-positive conditions may stem from their limited routine clinical utility, as their diagnosis and progression are already effectively managed via conventional clinical and histopathological evaluations. Furthermore, applying potentially painful QST stimuli to actively inflamed or ulcerated mucosa presents practical and ethical challenges that require a cautious approach and a clear hypothesis-driven rationale. Many of the available studies have also been conducted at single centers with relatively small sample sizes, which restricts their generalizability. Accordingly, multicenter studies using standardized protocols are required to establish the reliability and validity of oral QST across diverse populations and clinical settings. Furthermore, long-term follow-up data are scarce, limiting the current understanding of the prognostic significance of baseline sensory abnormalities and the temporal evolution of sensory dysfunction in chronic oral mucosal diseases. Finally, the relationship between the QST findings and treatment outcomes has not been sufficiently studied. Although some reports have shown that QST parameters can change after therapeutic interventions [10,29], further systematic investigation is required to determine whether baseline QST profiles can predict treatment responses. Such studies may ultimately support personalized treatment selection based on sensory phenotypes. 6. Future research priorities Several priorities for future research emerge from this review. First, standardized QST protocols specifically designed for the oral mucosa should be developed and validated. Such protocols must account for the unique anatomical and physiological properties of oral tissues and should be tested across multiple centers and diverse populations. In addition, the establishment of comprehensive normative databases stratified by age, sex, and ethnicity could improve the clinical interpretation of oral QST findings. Second, rather than broadly expanding QST as a stand-alone diagnostic tool for lesion-positive oral disorders, future research should cautiously target specific clinical questions that conventional assessments cannot fully answer. Specifically, QST can be used to objectively evaluate the efficacy of novel symptomatic pain therapies (such as topical analgesics, local anesthetics, or mucosal protectants) in clinical trials, moving beyond subjective pain scores. Additionally, well-designed comparative studies between lesion-negative neuropathic disorders (e.g., BMS) and lesion-positive inflammatory conditions can enhance our understanding of distinct peripheral and central pain mechanisms. Any future application of comprehensive QST batteries to active mucosal lesions must be strictly hypothesis-driven and must demonstrate a clear potential for meaningful patient benefits to justify the repeated application of sensory stimuli. Third, the integration of QST with complementary assessment modalities, including structural nerve imaging, histological analysis, and biomarker evaluation, may provide a more comprehensive understanding of oral mucosal diseases. QST is strictly a functional assessment tool that infers somatosensory pathway abnormalities (such as specific nerve fiber dysfunction or sensitization). Integrating these defined sensory phenotypes with parallel molecular, cellular, or histological analyses could better guide the identification of therapeutic targets and support precision medicine approaches. Fourth, the predictive value of QST for treatment outcomes should be investigated in prospective studies. Determining whether baseline sensory profiles can predict responses to specific interventions may facilitate personalized treatment selection, and the identification of sensory biomarkers associated with treatment responses would represent a meaningful advancement in oral pain management. Finally, simplified and clinically feasible sensory testing methods that preserve the diagnostic and prognostic values of comprehensive QST batteries should be developed to support broader clinical implementation. Although full QST protocols allow detailed somatosensory profiling, abbreviated approaches that focus on the most informative parameters may be more practical for routine clinical use. 7. Clinical implications Our findings underscore the growing clinical relevance of the QST. By providing an objective framework for characterizing somatosensory function, QST enables clinicians to differentiate between inflammatory and neuropathic pain mechanisms and to identify distinct sensitization patterns. Such distinctions are critical for selecting appropriate mechanism-based treatment strategies, particularly in conditions such as BMS, in which heterogeneous pathophysiological subtypes exist. In addition, QST may serve as a valuable adjunct to conventional clinical evaluations by supporting a more precise diagnosis in complex or ambiguous cases of oral pain. In addition to diagnosis, QST offers potential utility for prognostic assessment and treatment monitoring. Baseline sensory profiles may help identify patients at risk for persistent or chronic pain and guide early intervention strategies. Furthermore, the longitudinal assessment of QST parameters can provide objective measures of treatment response, complement patient-reported outcomes, and enable the detection of both therapeutic benefits and adverse sensory effects. This is particularly relevant for therapies that influence nerve function, including pharmacological, surgical, and regenerative interventions. Despite the clinical advantages, the routine clinical implementation of QST remains limited by the need for specialized equipment, standardized protocols, and trained personnel. The development of simplified testing approaches and integration with complementary diagnostic modalities, such as imaging, histology, and biomarker assessment may enhance diagnostic accuracy and support a more comprehensive understanding of oral mucosal diseases. Ultimately, the incorporation of QST into clinical practice has the potential to advance personalized mechanism-based management of oral pain conditions. CONCLUSION Sensory measurement methods, particularly QST, are valuable for evaluating somatosensory abnormalities in oral mucosal and oral pain disorders. They enable detailed somatosensory profiling, facilitate the detection of small-fiber neuropathy, and provide objective outcome measures to help differentiate underlying pain mechanisms. Thermal QST is particularly effective in identifying small-fiber dysfunction in BMS and other neuropathic oral pain conditions, whereas mechanical testing methods, including tactile detection and pressure pain threshold assessment, offer reliable and clinically accessible alternatives. However, despite these advances, several challenges remain. Methodological heterogeneity across studies, limited availability of normative reference values, and lack of standardized protocols tailored to the unique characteristics of the oral mucosa continue to limit the comparability and clinical translation of the findings. Addressing these issues is essential for advancing this field. Future research should prioritize the development and validation of intraoral-specific QST protocols, establishment of comprehensive normative databases, and expansion of research on understudied oral mucosal diseases. In addition, investigating the predictive value of sensory phenotypes for treatment outcomes may enable the development of more personalized mechanism-based therapeutic strategies. The integration of QST with structural, neurophysiological, and molecular assessments is also likely to provide deeper insight into pathophysiological mechanisms and facilitate the implementation of precision medicine approaches. As the field continues to evolve, sensory measurement methods are expected to play an increasingly important role in both the clinical research and personalized management of patients with oral mucosal diseases.